UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies

Cancer research (Chicago, Ill.), 2005-12, Vol.65 (24), p.11265-11270

2005

Volltextzugriff (PDF)

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy

Haematologica (Roma), 2019-02, Vol.104 (2), p.e68-e71

2019

Volltextzugriff (PDF)

Efficacy of Vemurafenib in Hairy-Cell Leukemia

The New England journal of medicine, 2014-01, Vol.370 (3), p.286-288

2014

Volltextzugriff (PDF)

Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia

Journal of clinical oncology, 2010-04, Vol.28 (10), p.1749-1755

2010

Volltextzugriff (PDF)

Voltage-gated proton channels maintain pH in human neutrophils during phagocytosis

Proceedings of the National Academy of Sciences - PNAS, 2009-10, Vol.106 (42), p.18022-18027

2009

Volltextzugriff (PDF)

HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species

Nature immunology, 2010-03, Vol.11 (3), p.265-272

2010

Volltextzugriff (PDF)

Specific interactions of BCL-2 family proteins mediate sensitivity to BH3-mimetics in diffuse large B-cell lymphoma

Haematologica (Roma), 2020-08, Vol.105 (8), p.2150-2163

2020

Volltextzugriff (PDF)

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma

American journal of hematology, 2016-09, Vol.91 (9), p.923-930

2016

Volltextzugriff (PDF)

pH regulation and beyond: unanticipated functions for the voltage-gated proton channel, HVCN1

Trends in cell biology, 2011-01, Vol.21 (1), p.20-28

2011

Volltextzugriff (PDF)

Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study

Haematologica (Roma), 2021-10, Vol.106 (10), p.2774-2778

2021

Volltextzugriff (PDF)

Identification of the gene encoding cyclin E1 (CCNE1) as a novel IGH translocation partner in t(14;19)(q32;q12) in diffuse large B-cell lymphoma

Haematologica (Roma), 2009-07, Vol.94 (7), p.1020-1023

2009

Volltextzugriff (PDF)

Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignancies

Haematologica (Roma), 2019-05, Vol.104 (5), p.1016-1025

2019

Volltextzugriff (PDF)

Humanized Anti-CD20 Antibody, Veltuzumab, in Refractory/Recurrent Non-Hodgkin's Lymphoma: Phase I/II Results

Journal of clinical oncology, 2009-07, Vol.27 (20), p.3346-3353

2009

Volltextzugriff (PDF)

Responses to the Selective Bruton's Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines

Cancers, 2018-04, Vol.10 (4), p.127

2018

Volltextzugriff (PDF)

Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma

Haematologica (Roma), 2017-04, Vol.102 (4), p.765-772

2017

Volltextzugriff (PDF)

Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis

Cancer research (Chicago, Ill.), 2006-07, Vol.66 (13), p.6785-6792

2006

Volltextzugriff (PDF)

Barriers to effective TRAIL-targeted therapy of malignancy

Journal of clinical oncology, 2007-10, Vol.25 (28), p.4505-4506

2007

Volltextzugriff (PDF)

Protein Profiling of Plasma Membranes Defines Aberrant Signaling Pathways in Mantle Cell Lymphoma

Molecular & cellular proteomics, 2009-07, Vol.8 (7), p.1501-1515

2009

Volltextzugriff (PDF)

DNA methylation profiling of hepatosplenic T-cell lymphoma

Haematologica (Roma), 2019-03, Vol.104 (3), p.e104-e107

2019

Volltextzugriff (PDF)

Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells

Haematologica (Roma), 2010-09, Vol.95 (9), p.1510-1518

2010

Volltextzugriff (PDF)

Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study

HemaSphere, 2023-07, Vol.7 (7), p.e919-n/a

2023

Volltextzugriff (PDF)

CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL

Leukemia research, 2011-06, Vol.35 (6), p.750-756

2011

Volltextzugriff (PDF)

ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele

Haematologica (Roma), 2012-01, Vol.97 (1), p.142-146

2012

Volltextzugriff (PDF)

1 – 25 von 235

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(212)

Publikationsform

Artikel
(235)

Sprache

Englisch
(235)
Japanisch
(29)

Erscheinungsjahr

n.n

Thema

Science & Technology
(168)
Humans
(163)
Life Sciences & Biomedicine
(162)
Hematology
(114)
Biological And Medical Sciences
(70)
Medical Sciences
(69)
Female
(66)
Male
(66)
Hematologic And Hematopoietic Diseases
(63)
Middle Aged
(63)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(59)
Aged
(55)
Oncology
(45)
Adult
(42)
Aged, 80 And Over
(29)
Leukemia
(29)
Leukemia, Lymphocytic, Chronic, B-Cell - Drug Therapy
(27)
Animals
(26)
Leukemia, Lymphocytic, Chronic, B-Cell - Genetics
(25)
Translocation, Genetic
(25)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

TRAIL receptor-selective mutants signal to apoptosis via TRAIL-R1 in primary lymphoid malignancies

Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy

Efficacy of Vemurafenib in Hairy-Cell Leukemia

Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia

Voltage-gated proton channels maintain pH in human neutrophils during phagocytosis

HVCN1 modulates BCR signal strength via regulation of BCR-dependent generation of reactive oxygen species

Specific interactions of BCL-2 family proteins mediate sensitivity to BH3-mimetics in diffuse large B-cell lymphoma

A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia

A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma

pH regulation and beyond: unanticipated functions for the voltage-gated proton channel, HVCN1

Acalabrutinib for treatment of diffuse large B-cell lymphoma: results from a phase Ib study

Identification of the gene encoding cyclin E1 (CCNE1) as a novel IGH translocation partner in t(14;19)(q32;q12) in diffuse large B-cell lymphoma

Targeting intermediary metabolism enhances the efficacy of BH3 mimetic therapy in hematologic malignancies

Humanized Anti-CD20 Antibody, Veltuzumab, in Refractory/Recurrent Non-Hodgkin's Lymphoma: Phase I/II Results

Responses to the Selective Bruton's Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell Lines

Safety and efficacy of obinutuzumab with CHOP or bendamustine in previously untreated follicular lymphoma

Inhibition of histone deacetylase class I but not class II is critical for the sensitization of leukemic cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis

Barriers to effective TRAIL-targeted therapy of malignancy

Protein Profiling of Plasma Membranes Defines Aberrant Signaling Pathways in Mantle Cell Lymphoma

DNA methylation profiling of hepatosplenic T-cell lymphoma

Role of NOXA and its ubiquitination in proteasome inhibitor-induced apoptosis in chronic lymphocytic leukemia cells

Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study

CD49d is an independent prognostic marker that is associated with CXCR4 expression in CLL

ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele

Suchergebnisse filtern